These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1300 related items for PubMed ID: 10934644

  • 1. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
    Quinn JM, Horwood NJ, Elliott J, Gillespie MT, Martin TJ.
    J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
    [Abstract] [Full Text] [Related]

  • 2. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
    Itoh K, Udagawa N, Matsuzaki K, Takami M, Amano H, Shinki T, Ueno Y, Takahashi N, Suda T.
    J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996
    [Abstract] [Full Text] [Related]

  • 3. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.
    Quinn JM, Itoh K, Udagawa N, Hausler K, Yasuda H, Shima N, Mizuno A, Higashio K, Takahashi N, Suda T, Martin TJ, Gillespie MT.
    J Bone Miner Res; 2001 Oct; 16(10):1787-94. PubMed ID: 11585342
    [Abstract] [Full Text] [Related]

  • 4. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
    Atkins GJ, Kostakis P, Welldon KJ, Vincent C, Findlay DM, Zannettino AC.
    J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
    [Abstract] [Full Text] [Related]

  • 5. MLO-Y4 osteocyte-like cells support osteoclast formation and activation.
    Zhao S, Zhang YK, Harris S, Ahuja SS, Bonewald LF.
    J Bone Miner Res; 2002 Nov; 17(11):2068-79. PubMed ID: 12412815
    [Abstract] [Full Text] [Related]

  • 6. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells.
    Kondo H, Guo J, Bringhurst FR.
    J Bone Miner Res; 2002 Sep; 17(9):1667-79. PubMed ID: 12211438
    [Abstract] [Full Text] [Related]

  • 7. Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation.
    Nagai M, Sato N.
    Biochem Biophys Res Commun; 1999 Apr 21; 257(3):719-23. PubMed ID: 10208850
    [Abstract] [Full Text] [Related]

  • 8. Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines.
    Nakashima T, Kobayashi Y, Yamasaki S, Kawakami A, Eguchi K, Sasaki H, Sakai H.
    Biochem Biophys Res Commun; 2000 Sep 07; 275(3):768-75. PubMed ID: 10973797
    [Abstract] [Full Text] [Related]

  • 9. Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation.
    Sun SG, Lau YS, Itonaga I, Sabokbar A, Athanasou NA.
    J Pathol; 2006 May 07; 209(1):114-20. PubMed ID: 16482498
    [Abstract] [Full Text] [Related]

  • 10. Breast cancer increases osteoclastogenesis by secreting M-CSF and upregulating RANKL in stromal cells.
    Mancino AT, Klimberg VS, Yamamoto M, Manolagas SC, Abe E.
    J Surg Res; 2001 Sep 07; 100(1):18-24. PubMed ID: 11516200
    [Abstract] [Full Text] [Related]

  • 11. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
    Kanatani M, Sugimoto T, Kano J, Kanzawa M, Chihara K.
    J Cell Physiol; 2003 Jul 07; 196(1):180-9. PubMed ID: 12767054
    [Abstract] [Full Text] [Related]

  • 12. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
    Chikazu D, Katagiri M, Ogasawara T, Ogata N, Shimoaka T, Takato T, Nakamura K, Kawaguchi H.
    J Bone Miner Res; 2001 Nov 07; 16(11):2074-81. PubMed ID: 11697804
    [Abstract] [Full Text] [Related]

  • 13. Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts.
    Chung YH, Chang EJ, Kim SJ, Kim HH, Kim HM, Lee SB, Ko JS.
    J Periodontal Res; 2006 Aug 07; 41(4):288-96. PubMed ID: 16827722
    [Abstract] [Full Text] [Related]

  • 14. Microrough implant surface topographies increase osteogenesis by reducing osteoclast formation and activity.
    Lossdörfer S, Schwartz Z, Wang L, Lohmann CH, Turner JD, Wieland M, Cochran DL, Boyan BD.
    J Biomed Mater Res A; 2004 Sep 01; 70(3):361-9. PubMed ID: 15293309
    [Abstract] [Full Text] [Related]

  • 15. Dual modulation of osteoclast differentiation by lipopolysaccharide.
    Zou W, Bar-Shavit Z.
    J Bone Miner Res; 2002 Jul 01; 17(7):1211-8. PubMed ID: 12096834
    [Abstract] [Full Text] [Related]

  • 16. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function.
    Takahashi N, Udagawa N, Suda T.
    Biochem Biophys Res Commun; 1999 Mar 24; 256(3):449-55. PubMed ID: 10080918
    [Abstract] [Full Text] [Related]

  • 17. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.
    Takayanagi H, Iizuka H, Juji T, Nakagawa T, Yamamoto A, Miyazaki T, Koshihara Y, Oda H, Nakamura K, Tanaka S.
    Arthritis Rheum; 2000 Feb 24; 43(2):259-69. PubMed ID: 10693864
    [Abstract] [Full Text] [Related]

  • 18. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD, Horwood NJ, Chuman Y, Fisher JL, Ellis J, Martin TJ, Rubin JS, Gillespie MT.
    J Bone Miner Res; 2004 Nov 24; 19(11):1873-81. PubMed ID: 15476588
    [Abstract] [Full Text] [Related]

  • 19. IL-1 alpha stimulates the formation of osteoclast-like cells by increasing M-CSF and PGE2 production and decreasing OPG production by osteoblasts.
    Tanabe N, Maeno M, Suzuki N, Fujisaki K, Tanaka H, Ogiso B, Ito K.
    Life Sci; 2005 Jun 24; 77(6):615-26. PubMed ID: 15921993
    [Abstract] [Full Text] [Related]

  • 20. Regulation of osteoclast differentiation and function by receptor activator of NFkB ligand and osteoprotegerin.
    Shiotani A, Takami M, Itoh K, Shibasaki Y, Sasaki T.
    Anat Rec; 2002 Oct 01; 268(2):137-46. PubMed ID: 12221720
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 65.